CIN 2/3

Clinical trials for CIN 2/3 explained in plain language.

Never miss a new study

Get alerted when new CIN 2/3 trials appear

Sign up with your email to follow new studies for CIN 2/3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

Could a malaria drug treat cervical Pre-Cancer?

Disease control Recruiting now

This phase II trial tests whether artesunate, a drug originally used for malaria, can reverse cervical pre-cancer (CIN2/3) when given as a vaginal insert. About 78 women with high-grade cervical lesions will receive either artesunate or a placebo for three 5-day cycles. The main …

Matched conditions: CIN 2/3

Phase: PHASE2 • Sponsor: Frantz Viral Therapeutics, LLC • Aim: Disease control

Last updated Jun 27, 2026 07:53 UTC

CIN 2/3

Get alerted when new CIN 2/3 trials appear

Could a malaria drug treat cervical Pre-Cancer?